Aarti Drugs Limited (NSE:AARTIDRUGS)
India · Delayed Price · Currency is INR 489.85
+0.40 (0.08%)
Aug 4, 2025, 1:30 PM IST
Aarti Drugs Employees
Aarti Drugs had 1,064 employees as of March 31, 2024. The number of employees increased by 61 or 6.08% compared to the previous year.
Employees
1,064
Change (1Y)
61
Growth (1Y)
6.08%
Revenue / Employee
22.77M INR
Profits / Employee
1.77M INR
Market Cap
44.99B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1,064 | 61 | 6.08% |
| Mar 31, 2023 | 1,003 | -447 | -30.83% |
| Mar 31, 2022 | 1,450 | -170 | -10.49% |
| Mar 31, 2021 | 1,620 | 84 | 5.47% |
| Mar 31, 2020 | 1,536 | 84 | 5.79% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Mankind Pharma | 26,978 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Aurobindo Pharma | 26,015 |
Aarti Drugs News
- 14 days ago - Aarti Drugs shares rise nearly 2% after strong Q1 results, net profit jumps 63% YoY - Business Upturn
- 16 days ago - Aarti Drugs Q1 Results: Revenue up 6.3% YoY to Rs 590 crore, Net Profit up 62.7% YoY - Business Upturn
- 3 months ago - Aarti Drugs share price jumps 6% as Q4 EBITDA rises 8.9% YoY to Rs 93.4 crore - Business Upturn
- 3 months ago - Aarti Drugs Q4 results: Revenue up 9.1% YoY to Rs 676.76 crore, Net profit rises 32% YoY - Business Upturn
- 6 months ago - Aarti Drugs receives US FDA clearance, removed from Import Alert 66-40 - Business Upturn
- 6 months ago - Aarti Drugs Ltd (BOM:524348) Q3 2025 Earnings Call Highlights: Navigating Revenue Decline with ... - GuruFocus
- 6 months ago - Aarti Drugs shares surge despite Q3 FY25 EBITDA margin falls to 11.1% - Business Upturn
- 6 months ago - Aarti Drugs Q3 FY25 results: Revenue down 8% to Rs 556.6 crore, Net Profit flat at Rs 37.09 crore - Business Upturn